event_bu

Tapan Kumar Singh Nayak

  • HOME /
  • Tapan Kumar Singh Nayak
Tapan Kumar Singh Nayak

Dr. Tapan Kumar Singh Nayak

Designation: Assistant Professor

Qualification: M.Sc. Biochemistry, PhD (Continuing)

Phone No.: 7978705931

ORCID: https://orcid.org/0009-0008-6993-0974

VIDWAN ID: 296127

Google Scholar ID: https://scholar.google.com/citations?user=6qksizwAAAAJ&hl=en

E-mail ID: tksn.bt@buodisha.edu.in , tapankumarsinghnayak@gmail.com

Biosketch

Tapan K. Singh Nayak has completed his M.Sc. in Biochemistry from the Department of Biochemistry, University of Hyderabad in the year 2009. He has qualified CSIR-UGC-JRF 2010 in Life Sciences and GATE 2010 in Life Sciences. ...

He is pursuing his Ph.D. from Dr. Reddy�s Institute of Life Sciences, University of Hyderabad. In the year 2018, he joined as an Assistant Professor in Khallikote University, Berhampur and since October, 2021 he is serving as an Assistant Professor in Berhampur University. His research area of interest precisely focuses on the molecular mechanisms underlying macrophage inflammatory responses. He has published his research work in several reputed peer-reviewed journals.

Macrophage inflammatory response and cell signalling- Immune responses/ inflammation is a tightly regulated processes required for the survival of the organisms. Our broad area of research interest lies in “Inflammation Biology”, in particular, to understand macrophage inflammatory responses and its various regulations dealing with innate immune response. The current focus of research is on Toll Like Receptor (TLR) signaling cascades and its post-translational modification regulations, particularly by ubiquitination and deubiquitination process.

  • Assistant Professor, Berhampur University, Berhampur, Odisha since 1st October, 2021 till date
  • Assistant Professor, Khallikote University, Berhampur, Odisha since 14th May, 2018 to 31st September 2021

  • Nayak TK, Alamuru-Yellapragada NP, Parsa KVL. Deubiquitinase USP12 promotes LPS induced macrophage responses through inhibition of IκBα. Biochem Biophys Res Commun. Volume 483, Issue 1, 29 January 2017, pages 69–74 (IF-3.32)
  • Talari M, Nayak TK, Kain V, Babu PP, Mishra P, Parsa KVL. MicroRNA712 restrains Macrophage pro-inflammatory responses by targeting LRRK leading to restoration of insulin stimulated glucose uptake by myoblasts. Molecular Immunology. Volume 82, February 2017, Pages 1–9 (IF-4.17)
  • Pati A, Padhi S, Nayak TKS, Panda AK. Angiotensin-Converting Enzyme 2 Genetic Variants Are Associated with Coronavirus Disease 2019. J Infect Dis. 2021 Dec 15;224(12):2181-2183. doi: 10.1093/infdis/jiab531. (IF-6.40)
  • Panda AK, Padhi S, Pati A, Nayak TKS. Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted. Hum Cell. 2021 Nov;34(6):1943-1944. doi: 10.1007/s13577-021- 00616-x. Epub 2021 Sep 15. (IF-4.37)

Five students have submitted their dissertation as a part of their M. Sc. Program.

Part of the ongoing Centre of Excellence project at Berhampur University entitled “Bioprospecting of Ethnopharmaceuticals of Southern Odisha to explore their potential against cancer, infectious and autoimmune diseases.”

Cell Biology, Biochemistry, Immunology, Vaccines, Molecular Diagnostics, Animal Biotechnology

  • Qualified CSIR-UGC Junior Research Fellowship (JRF) in Life Sciences in 2010
  • Qualified Graduate Aptitude Test for Engineering (GATE) in Life Sciences in 2010